Reneo Pharmaceuticals
Latest round
- Series B
Last raised
- Dec 2020
Total raised
- $72M
Investors
- 9
About Reneo Pharmaceuticals
Reneo Pharmaceuticals, Inc.Founded in 2014 and headquartered in San Diego, US, Reneo Pharmaceuticals, Inc. focuses on developing therapeutics for mitochondrial diseases.Reneo Pharmaceuticals specializes in the development of innovative therapeutics to address mitochondrial diseases and rare metabolic disorders. Their pipeline includes drug candidates targeting mitochondrial dysfunction, particularly aimed at enhancing cellular energy production and reducing oxidative stress.Reneo Pharmaceuticals generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research institutions. Revenue is primarily derived from milestone payments and royalties linked to their clinical programs, as well as potential future product sales upon successful commercialization.00 mn secured through a private placement in May 2023 to advance the development of REN001 across several areas of unmet need, including primary mitochondrial myopathies, fatty acid oxidation disorders, and McArdle disease. The company aims to expand its market presence further into the US and select European markets, enhancing its therapeutic offerings by targeting the needs of healthcare providers and patients suffering from rare metabolic conditions.
Who invested in Reneo Pharmaceuticals
9 investors across 2 rounds
See all investors in Reneo Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Reneo Pharmaceuticals
Who invested in Reneo Pharmaceuticals?
Reneo Pharmaceuticals has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Reneo Pharmaceuticals raised?
Reneo Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Reneo Pharmaceuticals last raise money?
Reneo Pharmaceuticals's most recent round on record is a Series B, in Dec 2020.
What does Reneo Pharmaceuticals do?
Reneo Pharmaceuticals is a pharmaceuticals company.
Where is Reneo Pharmaceuticals headquartered?
Reneo Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Reneo Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Reneo Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Reneo Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.